Top

Journal of Cardiovascular Translational Research

Published in:

01-02-2020 | Stroke | Review

Gender Differences in Arrhythmias: Focused on Atrial Fibrillation

Authors: Xiao-Ting Tian, Ying-Jia Xu, Yi-Qing Yang

Published in: Journal of Cardiovascular Translational Research | Issue 1/2020

Abstract

There are significant differences in clinical presentation and treatment of atrial fibrillation (AF) between women and men. The primary goal of AF management is to restore sinus rhythm and to prevent various complications, including stroke and heart failure. In many areas of AF, such as prevalence, clinical manifestations, morbidity, risk factors, pathophysiology, treatment strategies, and complications, gender-specific variability is observed and needs to be further addressed by large-scale population researches or randomized clinical trials, which help to promote the customization of AF treatment programs, hence to maximize the success rate of AF therapy in both sexes. This review highlights our current understanding of these gender differences in AF and how these differences affect treatment decisions on AF.

Roberts-Thomson, K. C., Lau, D. H., & Sanders, P. (2011). The diagnosis and management of ventricular arrhythmias. Nature Reviews. Cardiology, 8, 311–321.PubMed

Kannel, W. B., & Benjamin, E. J. (2009). Current perceptions of the epidemiology of atrial fibrillation. Cardiology Clinics, 27, 13–24.PubMedPubMedCentral

Andrade, J. G., Deyell, M. W., Lee, A. Y. K., & Macle, L. (2018). Sex differences in atrial fibrillation. The Canadian Journal of Cardiology, 34, 429–436.PubMed

Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946–952.PubMed

Ball, J., Carrington, M. J., Wood, K. A., & Stewart, S. (2013). Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). PLoS ONE, 8, e65795.PubMedPubMedCentral

Grisanti, L. A. (2018). Diabetes and arrhythmias: pathophysiology, mechanisms and therapeutic outcomes. Frontiers in Physiology, 9, 1669.PubMedPubMedCentral

Curtis, A. B., & Narasimha, D. (2012). Arrhythmias in women. Clinical Cardiology, 35, 166–171.PubMedPubMedCentral

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland Jr., J. C., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 64, e1–e76.PubMed

Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., et al. (2014). Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45, 1545–1588.PubMed

10.

van der Does, L. J., Yaksh, A., Kik, C., Knops, P., Lanters, E. A., Teuwen, C. P., et al. (2016). QUest for the arrhythmogenic substrate of atrial fibrillation in patients undergoing cardiac surgery (QUASAR Study): rationale and design. Journal of Cardiovascular Translational Research, 9, 194–201.PubMedPubMedCentral

11.

Hussain, S. K., Malhotra, R., & DiMarco, J. P. (2014). Left atrial appendage devices for stroke prevention in atrial fibrillation. Journal of Cardiovascular Translational Research, 7, 458–464.PubMed

12.

Andrade, J., Khairy, P., Dobrev, D., & Nattel, S. (2014). The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circulation Research, 114, 1453–1468.PubMed

13.

Bazemore, T. C., Bolger, L. E., Sears, S. F., Sadaf, M. I., & Gehi, A. K. (2018). Gender differences in symptoms and functional status in patients with atrial fibrillation undergoing catheter ablation. Pacing and Clinical Electrophysiology, 42, 224–229.PubMed

14.

Ko, D., Rahman, F., Schnabel, R. B., Yin, X., Benjamin, E. J., & Christophersen, I. E. (2016). Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nature Reviews. Cardiology, 13, 321–332.PubMedPubMedCentral

15.

Blum, S., Muff, C., Aeschbacher, S., Ammann, P., Erne, P., Moschovitis, G., et al. (2017). Prospective assessment of sex-related differences in symptom status and health perception among patients with atrial fibrillation. Journal of the American Heart Association, 6, e005401.PubMedPubMedCentral

16.

Schnabel, R. B., Pecen, L., Ojeda, F. M., Lucerna, M., Rzayeva, N., Blankenberg, S., et al. (2017). Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation. Heart, 103, 1024–1030.PubMedPubMedCentral

17.

Dagres, N., Nieuwlaat, R., Vardas, P. E., Andresen, D., Levy, S., Cobbe, S., et al. (2007). Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. Journal of the American College of Cardiology, 49, 572–577.PubMed

18.

Lip, G. Y., Laroche, C., Boriani, G., Cimaglia, P., Dan, G. A., Santini, M., et al. (2015). Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot Survey on Atrial Fibrillation. Eur Pacing Arrhythmias Cardiac Electrophysiol, 17, 24–31.

19.

Piccini, J. P., Simon, D. N., Steinberg, B. A., Thomas, L., Allen, L. A., Fonarow, G. C., et al. (2016). Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF Registry. Journal of the American Medical Association Cardiology, 1, 282–291.PubMed

20.

Alonso, A., Agarwal, S. K., Soliman, E. Z., Ambrose, M., Chamberlain, A. M., Prineas, R. J., et al. (2009). Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. American Heart Journal, 158, 111–117.PubMedPubMedCentral

21.

Svennberg, E., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman, V., & Rosenqvist, M. (2015). Mass screening for untreated atrial fibrillation: the STROKESTOP Study. Circulation, 131, 2176–2184.PubMed

22.

Benjamin, E. J., Levy, D., Vaziri, S. M., D'Agostino, R. B., Belanger, A. J., & Wolf, P. A. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Journal of the American Medical Association, 271, 840–844.PubMed

23.

Bunch, T. J., May, H. T., Bair, T. L., Jacobs, V., Crandall, B. G., Cutler, M., et al. (2016). The impact of age on 5-year outcomes after atrial fibrillation catheter ablation. Journal of Cardiovascular Electrophysiology, 27, 141–146.PubMed

24.

Zoller, B., Ohlsson, H., Sundquist, J., & Sundquist, K. (2012). High familial risk of atrial fibrillation/atrial flutter in multiplex families: a nationwide family study in Sweden. Journal of the American Heart Association, 2, e003384.PubMed

25.

Mohanty, S., Trivedi, C., Gianni, C., & Natale, A. (2018). Gender specific considerations in atrial fibrillation treatment: a review. Expert Opinion on Pharmacotherapy, 19, 365–374.PubMed

26.

Ravn, L. S., Hofman-Bang, J., Dixen, U., Larsen, S. O., Jensen, G., Haunso, S., et al. (2005). Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. The American Journal of Cardiology, 96, 405–407.PubMed

27.

Azarbal, F., Stefanick, M. L., Salmoirago-Blotcher, E., Manson, J. E., Albert, C. M., LaMonte, M. J., et al. (2014). Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. Journal of the American Heart Association, 3, e001127.PubMedPubMedCentral

28.

Mohanty, S., Mohanty, P., Di Biase, L., Bai, R., Dixon, A., Burkhardt, D., et al. (2011). Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation. Heart Rhythm, 8, 1847–1852.PubMed

29.

Karasoy, D., Bo Jensen, T., Hansen, M. L., Schmiegelow, M., Lamberts, M., Gislason, G. H., et al. (2013). Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. European Pacing, Arrhythmias, and Cardiac Electrophysiology, 15, 781–786.PubMed

30.

Grundvold, I., Bodegard, J., Nilsson, P. M., Svennblad, B., Johansson, G., Ostgren, C. J., et al. (2015). Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes: an observational study. Cardiovascular Diabetology, 14, 5.PubMedPubMedCentral

31.

Kang, S. H., Choi, E. K., Han, K. D., Lee, S. R., Lim, W. H., Cha, M. J., et al. (2016). Underweight is a risk factor for atrial fibrillation: a nationwide population-based study. International Journal of Cardiology, 215, 449–456.PubMed

32.

Inoue, H., Kodani, E., Atarashi, H., Okumura, K., Yamashita, T., & Origasa, H. (2016). Impact of body mass index on the prognosis of Japanese patients with non-valvular atrial fibrillation. The American Journal of Cardiology, 118, 215–221.PubMed

33.

Zhu, W., Wan, R., Liu, F., Hu, J., Huang, L., Li, J., et al. (2016). Relation of body mass index with adverse outcomes among patients with atrial fibrillation: a meta-analysis and systematic review. Journal of the American Heart Association, 5, e004006.PubMedPubMedCentral

34.

Park, C. S., Choi, E. K., Kim, H. M., Lee, S. R., Cha, M. J., & Oh, S. (2017). Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants. Heart Rhythm, 14, 501–507.PubMed

35.

Yang, P. C., Kurokawa, J., Furukawa, T., & Clancy, C. E. (2010). Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study. PLoS Computational Biology, 6, e1000658.PubMedPubMedCentral

36.

Nakamura, H., Kurokawa, J., Bai, C. X., Asada, K., Xu, J., Oren, R. V., et al. (2007). Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation, 116, 2913–2922.PubMed

37.

Liu, X. K., Katchman, A., Drici, M. D., Ebert, S. N., Ducic, I., Morad, M., et al. (1998). Gender difference in the cycle length-dependent QT and potassium currents in rabbits. The Journal of Pharmacology and Experimental Therapeutics, 285, 672–679.PubMed

38.

Drici, M. D., Burklow, T. R., Haridasse, V., Glazer, R. I., & Woosley, R. L. (1996). Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation, 94, 1471–1474.PubMed

39.

Stramba-Badiale, M., Locati, E. H., Martinelli, A., Courville, J., & Schwartz, P. J. (1997). Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. European Heart Journal, 18, 1000–1006.PubMed

40.

Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D., et al. (2015). 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet, 386, 154–162.PubMedPubMedCentral

41.

Tedrow, U. B., Conen, D., Ridker, P. M., Cook, N. R., Koplan, B. A., Manson, J. E., et al. (2010). The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). Journal of the American College of Cardiology, 55, 2319–2327.PubMedPubMedCentral

42.

Dahlqvist, S., Rosengren, A., Gudbjornsdottir, S., Pivodic, A., Wedel, H., Kosiborod, M., et al. (2017). Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study. The Lancet Diabetes and Endocrinology, 5, 799–807.PubMed

43.

Mendez-Bailon, M., Munoz-Rivas, N., Jimenez-Garcia, R., Hernandez-Barrera, V., de Miguel-Yanes, J. M., Villalba, N. L., et al. (2017). Women with atrial fibrillation and type 2 diabetes have a higher incidence of hospitalization and undergo ablation or pacemaker implantation less frequently than men. European Journal of Internal Medicine, 42, 67–73.PubMed

44.

Inoue, H., Atarashi, H., Okumura, K., Yamashita, T., Origasa, H., Kumagai, N., et al. (2014). Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation. The American Journal of Cardiology, 113, 957–962.PubMed

45.

Bukari, A., Nayak, H., Aziz, Z., Deshmukh, A., Tung, R., & Ozcan, C. (2017). Impact of race and gender on clinical outcomes of catheter ablation in patients with atrial fibrillation. Pacing and Clinical Electrophysiology, 40, 1073–1079.PubMed

46.

Mohanty, S., Mohanty, P., Tamaki, M., Natale, V., Gianni, C., Trivedi, C., et al. (2016). Differential association of exercise intensity with risk of atrial fibrillation in men and women: evidence from a meta-analysis. Journal of Cardiovascular Electrophysiology, 27, 1021–1029.PubMed

47.

Kishi, S., Reis, J. P., Venkatesh, B. A., Gidding, S. S., Armstrong, A. C., Jacobs Jr., D. R., et al. (2015). Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Journal of the American Heart Association, 4, e001264.PubMedPubMedCentral

48.

Hudsmith, L. E., Petersen, S. E., Francis, J. M., Robson, M. D., & Neubauer, S. (2005). Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. Journal of Cardiovascular Magnetic Resonance, 7, 775–782.PubMed

49.

McManus, D. D., Xanthakis, V., Sullivan, L. M., Zachariah, J., Aragam, J., Larson, M. G., et al. (2010). Longitudinal tracking of left atrial diameter over the adult life course: clinical correlates in the community. Circulation, 121, 667–674.PubMedPubMedCentral

50.

Vaziri, S. M., Larson, M. G., Benjamin, E. J., & Levy, D. (1994). Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation, 89, 724–730.PubMed

51.

Takigawa, M., Kuwahara, T., Takahashi, A., Watari, Y., Okubo, K., Takahashi, Y., et al. (2013). Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. International Journal of Cardiology, 168, 1984–1991.PubMed

52.

Li, Z., Wang, Z., Yin, Z., Zhang, Y., Xue, X., Han, J., et al. (2017). Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation. Oncotarget, 8, 53714–53729.PubMedPubMedCentral

53.

Cochet, H., Mouries, A., Nivet, H., Sacher, F., Derval, N., Denis, A., et al. (2015). Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. Journal of Cardiovascular Electrophysiology, 26, 484–492.PubMed

54.

Nielsen, J. B., Pietersen, A., Graff, C., Lind, B., Struijk, J. J., Olesen, M. S., et al. (2013). Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study. Heart Rhythm, 10, 1249–1256.PubMed

55.

Santangeli, P., di Biase, L., Pelargonio, G., & Natale, A. (2011). Outcome of invasive electrophysiological procedures and gender: are males and females the same? Journal of Cardiovascular Electrophysiology, 22, 605–612.PubMed

56.

Xiong, Q., Proietti, M., Senoo, K., & Lip, G. Y. (2015). Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes. International Journal of Cardiology, 191, 172–177.PubMed

57.

Chapa, D. W., Akintade, B., Thomas, S. A., & Friedmann, E. (2015). Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: a systematic review. Heart & Lung, 44, 189–198.

58.

Wagstaff, A. J., Overvad, T. F., Lip, G. Y., & Lane, D. A. (2014). Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? a systematic review and meta-analysis. The Quarterly Journal of Medicine, 107, 955–967.

59.

Poli, D., Antonucci, E., Testa, S., Ageno, W., & Palareti, G. (2013). Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thrombosis Research, 131, 12–16.PubMed

60.

Ko, D., Rahman, F., Martins, M. A., Hylek, E. M., Ellinor, P. T., Schnabel, R. B., et al. (2017). Atrial fibrillation in women: treatment. Nature Reviews. Cardiology, 14, 113–124.PubMed

61.

Martin, R. C., Burgin, W. S., Schabath, M. B., Kirby, B., Chae, S. H., Fradley, M. G., et al. (2017). Gender-specific differences for risk of disability and death in atrial fibrillation-related stroke. The American Journal of Cardiology, 119, 256–261.PubMed

62.

Shantha, G. P. S., Mentias, A., Bhise, V., Kumar, A., Rasmussen, T., Adams, C., et al. (2017). Gender differences in the trends of hospitalizations for acute stroke among patients with atrial fibrillation in the United States: 2005 to 2014. The American Journal of Cardiology, 120, 1541–1548.PubMed

63.

Roten, L., Rimoldi, S. F., Schwick, N., Sakata, T., Heimgartner, C., Fuhrer, J., et al. (2009). Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing and Clinical Electrophysiology, 32, 622–626.PubMed

64.

Zhang, X. D., Tan, H. W., Gu, J., Jiang, W. F., Zhao, L., Wang, Y. L., et al. (2013). Efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation in women. Pacing and Clinical Electrophysiology, 36, 1236–1244.PubMed

65.

Machino-Ohtsuka, T., Seo, Y., Ishizu, T., Sugano, A., Atsumi, A., Yamamoto, M., et al. (2013). Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 62, 1857–1865.PubMed

66.

O'Neal, W. T., Sandesara, P., Hammadah, M., Venkatesh, S., Samman-Tahhan, A., Kelli, H. M., et al. (2017). Gender differences in the risk of adverse outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction. The American Journal of Cardiology, 119, 1785–1790.PubMedPubMedCentral

67.

Börschel, C. S., & Schnabel, R. B. (2019). The imminent epidemic of atrial fibrillation and its concomitant diseases—myocardial infarction and heart failure—a cause for concern. International Journal of Cardiology, 287, 162–173.PubMedPubMedCentral

68.

Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., et al. (2014). Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation, 129, 837–847.PubMed

69.

Patel, D., Mohanty, P., Di Biase, L., Sanchez, J. E., Shaheen, M. H., Burkhardt, J. D., et al. (2010). Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm, 7, 167–172.PubMed

70.

Ghani, A., Maas, A. H., Delnoy, P. P., Ramdat Misier, A. R., Ottervanger, J. P., & Elvan, A. (2011). Sex-based differences in cardiac arrhythmias, ICD utilisation and cardiac resynchronisation therapy. Netherlands Heart Journal, 19, 35–40.PubMed

71.

Rienstra, M., Van Veldhuisen, D. J., Hagens, V. E., Ranchor, A. V., Veeger, N. J., Crijns, H. J., et al. (2005). Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. Journal of the American College of Cardiology, 46, 1298–1306.PubMed

72.

Kerr, C. R., & Humphries, K. (2005). Gender-related differences in atrial fibrillation. Journal of the American College of Cardiology, 46, 1307–1308.PubMed

73.

Basili, S., Raparelli, V., Proietti, M., Napoleone, L., Ferroni, P., & Franconi, F. (2015). Old and new oral anticoagulants in management of atrial fibrillation: a double-edged sword for women. Current Vascular Pharmacology, 13, 738–748.PubMed

74.

Pancholy, S. B., Sharma, P. S., Pancholy, D. S., Patel, T. M., Callans, D. J., & Marchlinski, F. E. (2014). Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. The American Journal of Cardiology, 113, 485–490.PubMed

75.

Moseley, A., Doukky, R., Williams, K. A., Jaffer, A. K., & Volgman, A. S. (2017). Indirect comparison of novel oral anticoagulants in women with nonvalvular atrial fibrillation. Journal of Women's Health, 26, 214–221.PubMed

76.

Alotaibi, G. S., Almodaimegh, H., McMurtry, M. S., & Wu, C. (2013). Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. Thrombosis Research, 132, 185–189.PubMed

77.

Bai, Y., Deng, H., Shantsila, A., & Lip, G. Y. (2017). Rivaroxaban versus dabigatran or Warfarin in real-world studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis. Stroke, 48, 970–976.PubMed

78.

Iles, T. L., Quallich, S. G., & Iaizzo, P. A. (2018). Identification of radiofrequency ablation catheter parameters that may induce intracardiac steam pops: direct visualization of elicitation in reanimated swine hearts. Journal of Cardiovascular Translational Research, 12, 250–256.PubMed

79.

Hakalahti, A., Biancari, F., Nielsen, J. C., & Raatikainen, M. J. (2015). Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Eur Pacing Arrhythmias Cardiac Electrophysiol, 17, 370–378.

80.

Boucebci, S., Pambrun, T., Velasco, S., Duboe, P. O., Ingrand, P., & Tasu, J. P. (2016). Assessment of normal left atrial appendage anatomy and function over gender and ages by dynamic cardiac CT. European Radiology, 26, 1512–1520.PubMed

81.

Yu, H. T., Lee, J. S., Kim, T. H., Uhm, J. S., Joung, B., Hong, G. R., et al. (2016). Advanced left atrial remodeling and appendage contractile dysfunction in women than in men among the patients with atrial fibrillation: potential mechanism for stroke. Journal of the American Heart Association, 5, e003361.PubMedPubMedCentral

82.

Nishimura, M., Lupercio-Lopez, F., & Hsu, J. C. (2019). Left atrial appendage electrical isolation as a target in atrial fibrillation. Journal of American College of Cardiology Clinical electrophysiology, 5, 407–416.PubMed

83.

Wagner, M. K., Zwisler, A. O., Risom, S. S., Svendsen, J. H., Christensen, A. V., & Berg, S. K. (2018). Sex differences in health status and rehabilitation outcomes in patients with atrial fibrillation treated with ablation: results from the CopenHeartRFA trial. European Journal of Cardiovascular Nursing, 17, 123–135.PubMed

84.

Rodriguez, L. M., de Chillou, C., Schlapfer, J., Metzger, J., Baiyan, X., van den Dool, A., et al. (1992). Age at onset and gender of patients with different types of supraventricular tachycardias. The American Journal of Cardiology, 70, 1213–1215.PubMed

85.

Go, A. S., Hlatky, M. A., Liu, T. I., Fan, D., Garcia, E. A., Sung, S. H., et al. (2018). Contemporary burden and correlates of symptomatic paroxysmal supraventricular tachycardia. Journal of the American Heart Association, 7, e008759.PubMedPubMedCentral

86.

Hosseini, S. M., Rozen, G., Saleh, A., Vaid, J., Biton, Y., Moazzami, K., et al. (2017). Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. J Am Coll Cardiol Clin Electrophysiol, 3, 1240–1248.

87.

Rosengren, P., Li, X., Sundquist, J., Sundquist, K., & Zoller, B. (2018). Hospitalization rate of paroxysmal supraventricular tachycardia in Sweden. Annals of Medicine, 50, 556–564.PubMedPubMedCentral

88.

Rosano, G. M., Leonardo, F., Sarrel, P. M., Beale, C. M., De Luca, F., & Collins, P. (1996). Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet, 347, 786–788.PubMed

89.

Myerburg, R. J., Cox, M. M., Interian Jr., A., Mitrani, R., Girgis, I., Dylewski, J., et al. (1999). Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiologic procedures. The American Journal of Cardiology, 83, 1049–1054.PubMed

90.

Dagres, N., Clague, J. R., Breithardt, G., & Borggrefe, M. (2003). Significant gender-related differences in radiofrequency catheter ablation therapy. Journal of the American College of Cardiology, 42, 1103–1107.PubMed

91.

Vink, A. S., Clur, S. B., Geskus, R. B., Blank, A. C., De Kezel, C. C., Yoshinaga, M., et al. (2017). Effect of age and sex on the QTc interval in children and adolescents with type 1 and 2 long-QT syndrome. Circulation. Arrhythmia and Electrophysiology, 10, e004645.PubMed

92.

Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J., et al. (1991). The long QT syndrome. Prospective longitudinal study of 328 families. Circulation, 84, 1136–1144.PubMed

93.

Garson Jr., A., Dick 2nd, M., Fournier, A., Gillette, P. C., Hamilton, R., Kugler, J. D., et al. (1993). The long QT syndrome in children. An international study of 287 patients. Circulation, 87, 1866–1872.PubMed

94.

Moss, A. J., Schwartz, P. J., Crampton, R. S., Locati, E., & Carleen, E. (1985). The long QT syndrome: a prospective international study. Circulation, 71, 17–21.PubMed

95.

Locati, E. H., Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Lehmann, M. H., et al. (1998). Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation, 97, 2237–2244.PubMed

96.

Aarnoudse, A. J., Newton-Cheh, C., de Bakker, P. I., Straus, S. M., Kors, J. A., Hofman, A., et al. (2007). Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation, 116, 10–16.PubMed

97.

Crotti, L., Monti, M. C., Insolia, R., Peljto, A., Goosen, A., Brink, P. A., et al. (2009). NOS1AP is a genetic modifier of the long-QT syndrome. Circulation, 120, 1657–1663.PubMedPubMedCentral

98.

Tomas, M., Napolitano, C., De Giuli, L., Bloise, R., Subirana, I., Malovini, A., et al. (2010). Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. Journal of the American College of Cardiology, 55, 2745–2752.PubMed

99.

Winbo, A., Stattin, E. L., Westin, I. M., Norberg, A., Persson, J., Jensen, S. M., et al. (2017). Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis. BMC Medical Genetics, 18, 74.PubMedPubMedCentral

100.

Antzelevitch, C., & Shimizu, W. (2002). Cellular mechanisms underlying the long QT syndrome. Current Opinion in Cardiology, 17, 43–51.PubMed

101.

Drici, M. D., Knollmann, B. C., Wang, W. X., & Woosley, R. L. (1998). Cardiac actions of erythromycin: influence of female sex. Journal of the American Medical Association, 280, 1774–1776.PubMed

102.

Wolbrette, D. L. (2003). Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. The American Journal of Cardiology, 91, 39d–44d.PubMed

103.

Kawasaki, R., Machado, C., Reinoehl, J., Fromm, B., Baga, J. J., Steinman, R. T., et al. (1995). Increased propensity of women to develop torsades de pointes during complete heart block. Journal of Cardiovascular Electrophysiology, 6, 1032–1038.PubMed

104.

Gourraud, J. B., Barc, J., Thollet, A., Le Scouarnec, S., Le Marec, H., Schott, J. J., et al. (2016). The Brugada syndrome: a rare arrhythmia disorder with complex inheritance. Frontiers in Cardiovascular Medicine, 3, 9.PubMedPubMedCentral

105.

Benito, B., Sarkozy, A., Mont, L., Henkens, S., Berruezo, A., Tamborero, D., et al. (2008). Gender differences in clinical manifestations of Brugada syndrome. Journal of the American College of Cardiology, 52, 1567–1573.PubMed

106.

MacIntyre, C., Iwuala, C., & Parkash, R. (2018). Cardiac arrhythmias and pregnancy. Current Treatment Options in Cardiovascular Medicine, 20, 63.PubMed

107.

Wenger, N. K., Hurst, J. W., & Strozier, V. N. (1964). Electrocardiographic changes in preganancy. The American Journal of Cardiology, 13, 774–778.PubMed

108.

Tawam, M., Levine, J., Mendelson, M., Goldberger, J., Dyer, A., & Kadish, A. (1993). Effect of pregnancy on paroxysmal supraventricular tachycardia. The American Journal of Cardiology, 72, 838–840.PubMed

109.

Knotts, R. J., & Garan, H. (2014). Cardiac arrhythmias in pregnancy. Seminars in Perinatology, 38, 285–288.PubMed

110.

Widerhorn, J., Widerhorn, A. L., Rahimtoola, S. H., & Elkayam, U. (1992). WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. American Heart Journal, 123, 796–798.PubMed

Title: Gender Differences in Arrhythmias: Focused on Atrial Fibrillation
Authors: Xiao-Ting Tian
Ying-Jia Xu
Yi-Qing Yang
Publication date: 01-02-2020
Publisher: Springer US
Keywords: Stroke
Atrial Fibrillation
Published in: Journal of Cardiovascular Translational Research / Issue 1/2020
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-019-09918-w

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Gender Differences in Arrhythmias: Focused on Atrial Fibrillation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

Gender Differences in Hypertension

Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study Design

Vascular Pathways of Testosterone: Clinical Implications

Gender-Specific Predictive Markers of Poor Prognosis for Patients with Acute Myocardial Infarction During a 6-Month Follow-up

Gender Differences in Prognostic Markers of All-Cause Death in Patients with Acute Heart Failure: a Prospective 18-Month Follow-Up Study

Gender Differences in Cardiac Hypertrophy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page